A heterogeneous mixture of amyloid beta (Aβ) variants exists in Alzheimer’s disease (AD) brains. So far, little is known how individual Aβ species contribute to development and progression of this neurodegenerative disorder. Several studies revealed an important role of N-terminally truncated Aβ species in AD etiology. Besides other Aβ isoforms, N-truncated Aβ4-42 is highly abundant in AD brains and is one of two dominant isoforms in the hippocampus and cortex of sporadic and familial AD subjects. In a recent work it was demonstrated that Aβ4-42 exhibits one of the highest aggregation propensities to form stable aggregates. Moreover, it demonstrates strong toxic effects when studied in primary cortical neurons and is able to induce workin...
Alzheimer's disease (AD) is a uniquely human disorder. Although the pathogenesis of AD is not fully ...
BACKGROUND: The molecular heterogeneity of Alzheimer's amyloid-β (Aβ) deposits extends well beyond t...
Alzheimer’s disease (AD) is a progressive neurodegenerative condition characterized by behavioral ch...
The N-terminally truncated pyroglutamate Aβ3−42 (AβpE3−42) and Aβ4−42 peptides are known to be highl...
This commentary reviews the role of the Alzheimer amyloid peptide Aβ on basal synaptic transmission,...
Abstract Background The amyloid hypothesis in Alzheim...
Amyloid pathology in Alzheimer’s disease (AD) is characterized by a heterogeneity of amyloid-β pepti...
Detecting and treating Alzheimer's disease, before cognitive deficits occur, has become the health c...
Alzheimer's disease is a neurodegenerative disease and the most common form of dementia. Hyperphosph...
AbstractThe neuropathological correlates of Alzheimer's disease (AD) include amyloid-β (Aβ) plaques ...
SummaryProgressive memory loss and cognitive dysfunction are the hallmark clinical features of Alzhe...
Transgenic mice expressing mutant human amyloid precursor protein (APP) develop an age-dependent am...
Background: High levels of Aβ in the cerebral cortex distinguish demented Alzheimer’s disease (AD) f...
Alzheimer's disease (AD) is a chronic neurodegenerative disorder that is associated with progressive...
The N-terminally truncated pyroglutamate Aβ3−42 (AβpE3−42) and Aβ4−42 peptides are known to be highl...
Alzheimer's disease (AD) is a uniquely human disorder. Although the pathogenesis of AD is not fully ...
BACKGROUND: The molecular heterogeneity of Alzheimer's amyloid-β (Aβ) deposits extends well beyond t...
Alzheimer’s disease (AD) is a progressive neurodegenerative condition characterized by behavioral ch...
The N-terminally truncated pyroglutamate Aβ3−42 (AβpE3−42) and Aβ4−42 peptides are known to be highl...
This commentary reviews the role of the Alzheimer amyloid peptide Aβ on basal synaptic transmission,...
Abstract Background The amyloid hypothesis in Alzheim...
Amyloid pathology in Alzheimer’s disease (AD) is characterized by a heterogeneity of amyloid-β pepti...
Detecting and treating Alzheimer's disease, before cognitive deficits occur, has become the health c...
Alzheimer's disease is a neurodegenerative disease and the most common form of dementia. Hyperphosph...
AbstractThe neuropathological correlates of Alzheimer's disease (AD) include amyloid-β (Aβ) plaques ...
SummaryProgressive memory loss and cognitive dysfunction are the hallmark clinical features of Alzhe...
Transgenic mice expressing mutant human amyloid precursor protein (APP) develop an age-dependent am...
Background: High levels of Aβ in the cerebral cortex distinguish demented Alzheimer’s disease (AD) f...
Alzheimer's disease (AD) is a chronic neurodegenerative disorder that is associated with progressive...
The N-terminally truncated pyroglutamate Aβ3−42 (AβpE3−42) and Aβ4−42 peptides are known to be highl...
Alzheimer's disease (AD) is a uniquely human disorder. Although the pathogenesis of AD is not fully ...
BACKGROUND: The molecular heterogeneity of Alzheimer's amyloid-β (Aβ) deposits extends well beyond t...
Alzheimer’s disease (AD) is a progressive neurodegenerative condition characterized by behavioral ch...